Dr. Scott Rocklage is on the Forefront of the Pharmaceutical Industry

With an educational background that I cludes earning a Bachelor of Science (BS) degree from the University of California at Berkeley in Chemistry and a Doctor of Philosophy (PhD) degree from the Massachusetts Institute of Technology (MIT) also in Chemistry, Dr. Scott Rocklage is a mover and shaker in the world of pharmaceuticals. In 2003, Dr. Rocklage took on the challenges that 5AM Ventures offered and became a managing partner in 2004.

 

Dr. Rocklage has more than 30 years of experience in his chosen field and has experience in strategic leadership and healthcare management. His past employment opportunities included research and design development with Salutar and Catalytic, CEO and President of Nycomed Salutar and CEO and Chairman of Cubist Pharmaceuticals. He also led s team that received Food and Drug Administration (FDA) approval for three drug applications that included Cubicin, Teslascan and Omniscan. Dr. Rocklage also serves on the boards of Pulmatrix and Variation, WaveRx, Relypsa, and Semprus and Achaogen. He also serves on the Board of Associates of the Whitehead Institute.

 

5AM Ventures is committed to building life science companies. They work to assist such companies create value from the start of the new operation. 5AM takes a hands-on approach to company development, as well as a financial investment role. The company company works with entities that utilize technology to solve healthcare issues and address healthcare concerns through the use of cutting edge science and medicine. The companies also take novel and different approaches to help medical science diagnose, treat and work to prevent a variety of medical condition s.

 

The team at 5AM and Dr. Rocklage all have extensive backgrounds and expertise in finance, legal matters, operational matters and medicine and science fields. 5AM is often on board with companies at an early stage and work to set company policy, strategy, fundraising, business development and management recruiting. Dr. Rocklage’s team often serves as board members and take on short term operational roles for the companies they invest in. 5AM Ventures was established in 2002 and typically manages more than $1 billion in assets. The company team is made up more than 15 investment professionals and operates offices in Boston, Massachusetts and San Francisco, California. Dr. To klage is based in the Boston office.

 

Visit http://5amventures.com/team/scott-m-rocklage-phd/ to learn more.

Leave a Reply

Your email address will not be published. Required fields are marked *